Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) disagree about the use of booster vaccine. However, US health officials, some other countries and vaccine makers have said boosters were needed.
US is witnessing a resurgence in Covid-19 cases. However, there are some states that are faring better than previous weeks and booster shot against Covid-19 is being debated in the country. The federal government's push to introduce //widespread Covid-19 booster shots faced a test as a Food and Drug Administration (FDA) advisory panel met on Friday to weigh evidence on the extra jabs, a topic that has divided health officials, Xinhua news agency reported.
‘Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) disagree about the use of booster vaccine. However, US health officials, some other countries and vaccine makers have said boosters were needed.’
The outside panel of about 20 scientific advisers reviewed information about the Pfizer Inc. and BioNTech SE vaccine's declining protection against Covid-19 over time and on how people tolerated additional doses. Pfizer has asked regulators to clear booster shots for people 16 years and older, and the FDA, which this week said all the shots cleared for use in the country remain effective without boosters.
While US health officials, some other countries and vaccine makers have said boosters were needed, many scientists, including some inside the FDA and the CDC, disagree.
The FDA panel then voted to recommend Covid-19 booster shots for Americans 65 and older and those at high risk of severe illness, but rejecting a broader use.
"Anything short of a full-throated endorsement could complicate the Biden administration's plan to begin distributing extra shots next week to bolster immunity among the vaccinated and counter highly transmissible variants of the virus such as Delta," The Wall Street Journal said in a report on Friday.
Advertisement
Source-IANS